menu
    • menu

    Company profile for Bluejay Diagnostics

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bluejay Diagnostics, Inc. is a late-stage, pre-revenue diagnostics/medical device company focused on improving patient outcomes through the Symphony System, a more cost-effective, rapid, near-patient product candidate for triage and monitoring of disease progression in hospital and long-term acute care (LTAC) settings. Bluejay Diagnostics is focused on improving patient outcomes through a more cost efficient, rapid, near patie...
    Bluejay Diagnostics, Inc. is a late-stage, pre-revenue diagnostics/medical device company focused on improving patient outcomes through the Symphony System, a more cost-effective, rapid, near-patient product candidate for triage and monitoring of disease progression in hospital and long-term acute care (LTAC) settings. Bluejay Diagnostics is focused on improving patient outcomes through a more cost efficient, rapid, near patient product for triage, diagnosis, and monitoring of disease progression.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bluejay DiagnosticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    360 Massachusetts Ave Suite 203Acton, MA 01720
    Telephone
    Telephone
    844.327.7078
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bluejaydx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bluejay To Present Abstract At 2026 SAEM Annual Meeting
    Bluejay To Present Abstract At 2026 SAEM Annual Meeting

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254418/0/en/Bluejay-Announces-Abstract-Accepted-for-Presentation-at-the-2026-Society-of-Academic-Emergency-Medicine-SAEM-Annual-Meeting.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Bluejay Diagnostics Updates Corporate Status And 2026 Strategy
    Bluejay Diagnostics Updates Corporate Status And 2026 Strategy

    06 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3250942/0/en/Bluejay-Diagnostics-Provides-Corporate-Update-and-2026-Strategic-Outlook.html

    GLOBENEWSWIRE
    06 Mar 2026
    Share Share
    Bluejay Diagnostics Hits 545-Patient Milestone in SYMON II Study
    Bluejay Diagnostics Hits 545-Patient Milestone in SYMON II Study

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239041/0/en/Bluejay-Diagnostics-Successfully-Enrolls-545-Patients-in-SYMON-II-Study-and-Advances-Manufacturing-Readiness-into-2026.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Bluejay Diagnostics Announces 1-For-4 Reverse Stock Split
    Bluejay Diagnostics Announces 1-For-4 Reverse Stock Split

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226438/0/en/Bluejay-Diagnostics-Announces-1-for-4-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Bluejay Diagnostics Completes Commercial-Scale IL-6 Antibody
    Bluejay Diagnostics Completes Commercial-Scale IL-6 Antibody

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210856/0/en/Bluejay-Diagnostics-Announces-Completion-of-Commercial-Scale-IL-6-Antibody-Production.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Bluejay Diagnostics Advances Clinical Milestones And Partnerships
    Bluejay Diagnostics Advances Clinical Milestones And Partnerships

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184423/0/en/Bluejay-Diagnostics-Corporate-Update-Advancing-Clinical-Milestones-and-Strategic-Partnerships.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search